- Home
- YMAB vs BHR Comparison
YMAB vs BHR Comparison
Compare YMAB & BHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- BHR
- Stock Information
- Founded
- YMAB 2015
- BHR 2013
- Country
- YMAB United States
- BHR United States
- Employees
- YMAB N/A
- BHR N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- BHR Real Estate Investment Trusts
- Sector
- YMAB Health Care
- BHR Real Estate
- Exchange
- YMAB Nasdaq
- BHR Nasdaq
- Market Cap
- YMAB 192.4M
- BHR 171.6M
- IPO Year
- YMAB 2018
- BHR N/A
- Fundamental
- Price
- YMAB $8.51
- BHR $2.13
- Analyst Decision
- YMAB Buy
- BHR
- Analyst Count
- YMAB 11
- BHR 0
- Target Price
- YMAB $15.02
- BHR N/A
- AVG Volume (30 Days)
- YMAB 1.3M
- BHR 171.8K
- Earning Date
- YMAB 08-08-2025
- BHR 07-31-2025
- Dividend Yield
- YMAB N/A
- BHR 9.22%
- EPS Growth
- YMAB N/A
- BHR N/A
- EPS
- YMAB N/A
- BHR N/A
- Revenue
- YMAB $88,658,000.00
- BHR $715,161,000.00
- Revenue This Year
- YMAB N/A
- BHR N/A
- Revenue Next Year
- YMAB $15.23
- BHR $2.32
- P/E Ratio
- YMAB N/A
- BHR N/A
- Revenue Growth
- YMAB 4.92
- BHR N/A
- 52 Week Low
- YMAB $3.55
- BHR $1.80
- 52 Week High
- YMAB $16.11
- BHR $3.82
- Technical
- Relative Strength Index (RSI)
- YMAB 81.64
- BHR 38.99
- Support Level
- YMAB $4.16
- BHR $2.07
- Resistance Level
- YMAB $8.54
- BHR $2.24
- Average True Range (ATR)
- YMAB 0.24
- BHR 0.09
- MACD
- YMAB 0.47
- BHR -0.02
- Stochastic Oscillator
- YMAB 99.32
- BHR 20.93
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About BHR Braemar Hotels & Resorts Inc.
Braemar Hotels & Resorts Inc is a real estate investment trust company that invests in high revenue per available room, or RevPAR, luxury, upper-upscale and upscale hotels in gateway and resort locations. The firm operates in various U.S. states such as California, Texas, Washington, Philadelphia, Florida, and Illinois as well as Washington, D.C. and St. Thomas, U.S. Virgin Islands. The company operates through its direct hotel investment segment of the hotel lodging industry. Its revenue streams include rooms, food and beverage, and other. The firm's hotels operate under various brands, such as Marriott, Hilton, Courtyard, and, among others.